Long-Term Outcomes Among Two-Year Survivors of Autologous Hematopoietic Cell Transplant for Hodgkin and Diffuse Large B-Cell Lymphoma

BACKGROUND: Autologous hematopoietic cell transplant (autoHCT) is a standard therapy for relapsed Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL); however, long-term outcomes are not well described. METHODS: We analyzed survival, non-relapse mortality, late effects and subsequent ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Myers, Regina, Hill, Brian T., Shaw, Bronwen E., Kim, Soyoung, Millard, Heather R., Battiwalla, Minoo, Majhail, Navneet, Buchbinder, David, Lazarus, Hillard M., Savani, Bipin N., Flowers, Mary E.D., D’Souza, Anita, Ehrdardt, Matt, Langston, Amelia, Yared, Jean, Hayashi, Robert J., Daly, Andrew, Olsson, Richard F., Inamoto, Yoshi, Malone, Adriana K., DeFilipp, Zachariah, Margossian, Steven, Warwick, Anne, Jaglowski, Samantha, Beitinjaneh, Amer, Fung, Henry, Kasow, Kimberly, Marks, David I., Reynolds, Jana, Stockerl-Goldstein, Keith, Wirk, Baldeep M., Wood, William, Hamadani, Mehdi, Satwani, Prakash
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5871233/
https://ncbi.nlm.nih.gov/pubmed/29125192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados